Home / Conferences

Conferences

World Biosimilar Congress 2014

World Biosimilar Congress 2014
11-12 November 2013
Geneva, Switzerland

Biosimilars Asia

Collaborative Development and Successful Commercialisation

China remains an attractive destination for MNCs and regionals pharma players for biosimilars development. Risks are reduced through strategic alliances and partnerships with local Chinese manufacturers.

Cell Line Development & Engineering Asia

Optimizing Efficacy and Quality in Cell Line Development

The 3rd Annual Cell Line Development & EngineeringAsia provides a platform to facilitate discussion on accelerating cell line products time to market, increasing efficiency, efficacy and improving quality in the cell line development process.

Biomanufacturing

Asia’s Leading Forum on Manufacturing Investment, Development & Operational Excellence

The 4th Annual Biomanufacturing conference will bring together senior level executives within manufacturing, process development and operations from biopharmas, biotechs, CMOs, leading technology and equipment providers to discuss commercial and operational strategies.  It will evaluate the investment opportunities in Asia, feature leading case studies, showcase leading edge technology and more!

Biosimilars 2014

Informa Life Sciences’ 11th Annual Biosimilars Conference will take place on 21–22 May 2014 in Berlin, Germany. The meeting will involve two parallel conferences, with Conference 1 covering the latest developments in regulatory considerations and market access strategies for biosimilars and Conference 2 covering quality, comparability, analytical, non-clinical and clinical aspects. Topics to include:

Topics presented at the 16th IGPA conference on generics

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.

Report on 25th Annual EuroMeeting, 4-6 March 2013, Amsterdam, The Netherlands

Delegates at DIA’s 25th Anniversary of the EuroMeeting, held on 4–6 March 2013 in Amsterdam, The Netherlands, were offered the mouth watering prospect of more than 100 sessions across 17 themes, addressed by 300+ Speakers from EMA, European Commission, FDA and other national regulatory agencies. Most popular sessions included Implementation of the New Pharmacovigilance Legislation, the Regulatory Town Hall Meeting and the sell-out European Landscape on HTA - the EUnetHTA Joint Action. Eighteen pre-conference tutorials were led by an expert faculty and 120 students, young professional and patients all attended sessions created especially for them.

Patient power predominates at DIA Europe’s Clinical Forum

DIA Europe’s 2012 Clinical Forum in October this year promises to be an important multidisciplinary conference for all engaged in the clinical development and therapeutic use of medicines. The theme for 2012 is ‘The Empowered Patient’, an acknowledgement of the inescapable fact that the evolution of technology and electronic communication has given patients the ability to find and share health information which will impact their treatment choices – empowering them to become more engaged in their care and to participate in decisions about it.

Need for global development programme for biosimilars

There is now a crucial need for a framework that allows global biosimilars development.

Generics News Research General

more

Biosimilars News Research General

more